Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Inheritor Cell Technology logo — "The key to every biological problem must finally be sought...

Inheritor Cell Technology

"The key to every biological problem must finally be sought in the cell"​ -Edmund Beecher Wilson

Founded 2004 United States Arcadia, United States 3 employees Biotechnology, Pharmaceutical

General Information

Company Name Inheritor Cell Technology
Founded Year 2004
Location United States Arcadia, United States +1
Employees 3
Industries Biotechnology, Pharmaceutical
Social

Get notified when Inheritor Cell Technology moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Inheritor Cell Technology

Inheritor Cell Technology, Inc. is a biomedical clinic, focusing on stem cell research and clinical applications. The company is dedicated to developing stem cell preparation, application treatment, and pharmaceuticals, with an emphasis on human health services such as disease research, genetic testing, assisted reproduction, organ regeneration, and genetic science through human-derived biological sample banks. Dr. An serves as the Chief Medical Officer of ICT U.S. and is a renowned stem cell therapist with a substantial clinical treatment track record, backed by twenty-six National Institutes of Health (NIH) and Food and Drug Administration (FDA) clinical trial registrations, both of which have successfully passed Phase III clinical trials. Founded in 2004, the company operates within the biotechnology and pharmaceutical industries, with a vision for the future that not only involves the development of smarter machines through Artificial Intelligence (AI) but also prioritizes human health.

Taxonomy: Stem Cell Research, Clinical Applications, Biological Sample Banks, Genetic Testing, Assisted Reproduction, Organ Regeneration, Health Services, Pharmaceuticals, Disease Research, Regenerative Medicine, AI in Healthcare, Biomedical Technology, Therapeutic Applications, Clinical Trials, Medical Expertise

No funding data available for Inheritor Cell Technology yet.

Get notified when Inheritor Cell Technology raises funding

Inheritor Cell Technology Alternatives & Competitors

Inheritor Cell Technology vs
向榮生技UnicoCell Biomed
向榮生技UnicoCell Biomed Taiwan

#unicocell#unicocell biomed#Integrity #Grit #Quality #Science

12 employees
Health Care, Manufacturing
Inheritor Cell Technology vs
GIOSTAR
GIOSTAR United States

Pioneers In Innovative Stem Cell Science and Therapy

9 employees
Inheritor Cell Technology vs
Parse Biosciences
Parse Biosciences United States

Scalable Single Cell Sequencing Without the Instrument

Acquired
133 employees
Biotechnology, Life Sciences

FAQ About Inheritor Cell Technology

"The key to every biological problem must finally be sought in the cell"​ -Edmund Beecher Wilson
Inheritor Cell Technology was founded in 2004.
Inheritor Cell Technology is headquartered in Arcadia, United States.
Inheritor Cell Technology operates in the following industries: Biotechnology, Pharmaceutical.
Inheritor Cell Technology has approximately 3 employees.
Top alternatives and competitors to Inheritor Cell Technology include 向榮生技UnicoCell Biomed, GIOSTAR, Parse Biosciences, 苏州吉美瑞生医学科技有限公司, Blue Cell Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Inheritor Cell Technology and 向榮生技UnicoCell Biomed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Inheritor Cell Technology and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy